What Might Have Been: US FDA Acting Commissioner Woodcock Testifies In Senate

Acting FDA commissioner Janet Woodcock’s latest appearance before Senate Health Committee shows once again she could easily win enough votes for Senate confirmation in the job – and why she most likely won’t get the chance.

Washington DC Capitol dome detail with waving american flag

A US Senate Health Committee hearing on 4 November on the status of the US COVID-19 response began with a reminder that acting Food and Drug Administration commissioner Janet Woodcock has strong bipartisan support as head of the agency.

The senior Republican member of the committee, North Carolina’s Richard Burr, noted there are vacancies at both the FDA and...

More from Regulation

More from Policy & Regulation